Physician profile
Mark Galperin
NPI 1760424543
$1,967.07
in general payments reported to CMS, 2019-2025
17 companies · $14.78 in 2025
The $14.78 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,096 · 2020: $99.65 · 2021: $287 · 2022: $277 · 2023: $143 · 2024: $50.46 · 2025: $14.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $826.41 | 2019 | |
| Intrinsic Therapeutics | $313.23 | 2022-2023 | Barricaid Acd (Annular Closure Device) |
| Takeda Pharmaceuticals U.S.A., INC. | $198.59 | 2019-2021 | |
| Pfizer INC. | $160.28 | 2019-2021 | |
| Janssen Biotech, INC. | $87.31 | 2022-2023 | Stelara |
| Collegium Pharmaceutical, INC. | $63.61 | 2021 | |
| Painteq LLC | $54.05 | 2021 | |
| Novo Nordisk INC | $38.10 | 2024-2025 | Ozempic, Rybelsus |
| Daiichi Sankyo INC. | $35.28 | 2019 | |
| Almatica Pharma LLC | $31.85 | 2021 | |
| Abbvie INC. | $31.12 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $27.14 | 2024 | Voquezna |
| Assertio Therapeutics, INC. | $23.56 | 2019 | |
| Depuy Synthes Sales INC. | $20.80 | 2019 | |
| Amarin Pharma, INC. | $20.41 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.66 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Galperin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.